Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 6/20 | 0.53 |
| ▸ | FAP | Q12884 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
| ▸ | SPR | P35270 | 1/20 | 0.42 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
| ▸ | BRS3 | P32247 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TTK | P33981 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12233963 | 0.87 | P2RX7 (0.55) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL18701876 | 0.83 | P2RX7 (0.56) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL12332206 | 0.82 | P2RX7 (0.58) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL5935830 | 0.80 | P2RX7 (0.53) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL31612677 | 0.77 | P2RX7 (0.56) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL24996566 | 0.74 | P2RX7 (0.41) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL12835450 | 0.74 | P2RX7 (0.48) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL31612676 | 0.73 | P2RX7 (0.52) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL19467734 | 0.73 | P2RX7 (0.47) | P2RX7FAPDPP4DPP8DPP7 | |
| SCHEMBL9944486 | 0.73 | DPP4 (0.53) | DPP4DPP8DPP7SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120149683-A1 | SUBSTITUTED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES | MERCK SHARP & DOHME LLC | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149683-A1 | SUBSTITUTED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES | DPP4, DPP3, DPP7 | P2RX7 1910/4885FAP 40/4885DPP4 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.